{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": 30
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the deposition of α-synuclein amyloid fibrils. The A30P mutation increases aggregation propensity but does not alter the fibril structure.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein aggregation and the role of A30P mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses H/D exchange coupled with NMR spectroscopy, which is suitable for studying protein structure and dynamics.",
          "judgment": "Yes",
          "reasoning": "H/D exchange and NMR spectroscopy are widely accepted methods for studying amyloid fibril structure.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type and mutant controls, and experiments were repeated multiple times.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, ensuring the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were not explicitly detailed, but the results were consistent across multiple experiments.",
          "judgment": "Yes",
          "reasoning": "While detailed statistical analyses are lacking, the consistency of results supports the conclusion.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A30P mutation increases aggregation propensity without altering the fibril structure, supported by multiple controls and consistent experimental results."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": 46
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the deposition of α-synuclein amyloid fibrils. The E46K mutation increases phospholipid binding and filament assembly.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein aggregation and the role of E46K mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phospholipid binding assays and filament assembly assays, which are suitable for studying α-synuclein aggregation.",
          "judgment": "Yes",
          "reasoning": "These assays are widely accepted for studying α-synuclein aggregation.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type and mutant controls, and experiments were repeated multiple times.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, ensuring the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were not explicitly detailed, but the results were consistent across multiple experiments.",
          "judgment": "Yes",
          "reasoning": "While detailed statistical analyses are lacking, the consistency of results supports the conclusion.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The E46K mutation increases phospholipid binding and filament assembly, supported by multiple controls and consistent experimental results."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": 53
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the deposition of α-synuclein amyloid fibrils. The A53T mutation increases aggregation propensity and extends the fibril core.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein aggregation and the role of A53T mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses solid-state NMR spectroscopy, which is suitable for studying amyloid fibril structure.",
          "judgment": "Yes",
          "reasoning": "Solid-state NMR is widely accepted for studying amyloid fibril structure.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type and mutant controls, and experiments were repeated multiple times.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, ensuring the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were not explicitly detailed, but the results were consistent across multiple experiments.",
          "judgment": "Yes",
          "reasoning": "While detailed statistical analyses are lacking, the consistency of results supports the conclusion.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A53T mutation increases aggregation propensity and extends the fibril core, supported by multiple controls and consistent experimental results."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": 30
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the deposition of α-synuclein amyloid fibrils. The A30P mutation increases aggregation propensity but does not alter the fibril structure.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein aggregation and the role of A30P mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses H/D exchange coupled with NMR spectroscopy, which is suitable for studying protein structure and dynamics.",
          "judgment": "Yes",
          "reasoning": "H/D exchange and NMR spectroscopy are widely accepted methods for studying amyloid fibril structure.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type and mutant controls, and experiments were repeated multiple times.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, ensuring the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were not explicitly detailed, but the results were consistent across multiple experiments.",
          "judgment": "Yes",
          "reasoning": "While detailed statistical analyses are lacking, the consistency of results supports the conclusion.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A30P mutation increases aggregation propensity without altering the fibril structure, supported by multiple controls and consistent experimental results."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": 46
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the deposition of α-synuclein amyloid fibrils. The E46K mutation increases phospholipid binding and filament assembly.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein aggregation and the role of E46K mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phospholipid binding assays and filament assembly assays, which are suitable for studying α-synuclein aggregation.",
          "judgment": "Yes",
          "reasoning": "These assays are widely accepted for studying α-synuclein aggregation.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type and mutant controls, and experiments were repeated multiple times.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, ensuring the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were not explicitly detailed, but the results were consistent across multiple experiments.",
          "judgment": "Yes",
          "reasoning": "While detailed statistical analyses are lacking, the consistency of results supports the conclusion.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The E46K mutation increases phospholipid binding and filament assembly, supported by multiple controls and consistent experimental results."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": 53
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the deposition of α-synuclein amyloid fibrils. The A53T mutation increases aggregation propensity and extends the fibril core.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein aggregation and the role of A53T mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses solid-state NMR spectroscopy, which is suitable for studying amyloid fibril structure.",
          "judgment": "Yes",
          "reasoning": "Solid-state NMR is widely accepted for studying amyloid fibril structure.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type and mutant controls, and experiments were repeated multiple times.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, ensuring the validity of the assays.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses were not explicitly detailed, but the results were consistent across multiple experiments.",
          "judgment": "Yes",
          "reasoning": "While detailed statistical analyses are lacking, the consistency of results supports the conclusion.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A53T mutation increases aggregation propensity and extends the fibril core, supported by multiple controls and consistent experimental results."
    }
  ]
}